We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.53B
1-Year Est. Return 154.61%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+154.61%
3 Year Est. Return
+564.07%
5 Year Est. Return
+985.88%
10 Year Est. Return
–
AUM
$2.09B
AUM Growth
+$76.9M
Cap. Flow
-$52.7M
Cap. Flow %
-2.52%
Top 10 Hldgs %
44.54%
Holding
114
New
28
Increased
33
Reduced
17
Closed
24

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$38.4M
2
RVMD icon
Revolution Medicines
RVMD
+$30.3M
3
ROIV icon
Roivant Sciences
ROIV
+$29.5M
4
BSX icon
Boston Scientific
BSX
+$26M
5
MRK icon
Merck
MRK
+$20.2M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$64.8M
2
ISRG icon
Intuitive Surgical
ISRG
+$37.9M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$31.2M
4
PEN icon
Penumbra
PEN
+$31.1M
5
TFX icon
Teleflex
TFX
+$30.5M

Sector Composition

Rank Sector Weight
1 Healthcare 90.39%
2 Miscellaneous 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBIX icon
26
Neurocrine Biosciences
NBIX
$15.7B
$19.8M 0.95%
150,000
– –
GKOS icon
27
Glaukos
GKOS
$10.6B
$18.8M 0.9%
175,000
-150,000
-46% -$16.9M
ARWR icon
28
Arrowhead Research
ARWR
$12B
$18.8M 0.9%
300,000
+200,000
+200% +$12.7M
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$137B
$17.9M 0.85%
+40,000
New +$18.7M
ORIC icon
30
Oric Pharmaceuticals
ORIC
$1.37B
$17.7M 0.85%
1,400,000
+200,000
+17% +$2.27M
ALMS
31
Alumis Inc
ALMS
$2.9B
$17.6M 0.84%
+800,000
New +$20M
FMS icon
32
Fresenius Medical Care
FMS
$12.3B
$17.5M 0.84%
775,000
+125,000
+19% +$2.87M
ISRG icon
33
Intuitive Surgical
ISRG
$132B
$16.1M 0.77%
35,000
-75,000
-68% -$37.9M
QURE icon
34
uniQure
QURE
$3.38B
$14.7M 0.7%
900,000
– –
TARS icon
35
Tarsus Pharmaceuticals
TARS
$3.15B
$14M 0.67%
200,000
– –
GILD icon
36
Gilead Sciences
GILD
$181B
$13.9M 0.67%
+100,000
New +$14M
LLY icon
37
Eli Lilly
LLY
$1.05T
$13.8M 0.66%
15,000
-5,000
-25% -$5.07M
EW icon
38
Edwards Lifesciences
EW
$52B
$13.6M 0.65%
170,000
-155,000
-48% -$12.8M
MLYS icon
39
CALL
Mineralys Therapeutics
MLYS
$2.26B
$13.5M 0.65%
500,000
+250,000
+100% +$7.33M
COGT icon
40
Cogent Biosciences
COGT
$6.02B
$13.5M 0.64%
+350,000
New +$12.9M
ELAN icon
41
Elanco Animal Health
ELAN
$12B
$13.2M 0.63%
550,000
+300,000
+120% +$7.33M
MDGL icon
42
Madrigal Pharmaceuticals
MDGL
$12.3B
$13.1M 0.63%
+25,000
New +$11.9M
PRAX icon
43
Praxis Precision Medicines
PRAX
$9.63B
$12.9M 0.62%
40,000
– –
DNTH icon
44
Dianthus Therapeutics
DNTH
$5.92B
$12.6M 0.6%
150,000
-125,000
-45% -$7.24M
RGNX icon
45
Regenxbio
RGNX
$638M
$12.6M 0.6%
1,500,000
+300,000
+25% +$3.15M
DGX icon
46
Quest Diagnostics
DGX
$26.8B
$11.8M 0.56%
60,000
-15,000
-20% -$2.91M
XENE icon
47
Xenon Pharmaceuticals
XENE
$5.81B
$11.6M 0.56%
+200,000
New +$9.22M
ERAS icon
48
Erasca
ERAS
$6.31B
$11.3M 0.54%
+700,000
New +$8.27M
ANRO icon
49
Alto Neuroscience
ANRO
$1.38B
$11.2M 0.54%
500,000
+125,000
+33% +$2.32M
BIIB icon
50
Biogen
BIIB
$32.3B
$11M 0.53%
60,000
-40,000
-40% -$7.37M
1
2
3 4 5

Similar funds

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.53B AUM 24.4% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.54B AUM 18.96% 1-Year Est. Return
QT
Quantbot Technologies New York $2.54B AUM 22.25% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.53B AUM 37.62% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.54B AUM 23.56% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.54B AUM 17.62% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.52B AUM 26.26% 1-Year Est. Return

Integral Health Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Integral Health Asset Management held 114 positions worth $2.09B, up 3.8% from $2.01B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Integral Health Asset Management's Q1 2026 filing shows 28 new, 33 increased, 17 reduced and 24 closed positions. Its largest new stake was Alumis Inc: 800,000 shares worth $17.6M. The largest sale was Medtronic, an estimated $64.8M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 98% a quarter earlier, followed by Miscellaneous.

  • Integral Health Asset Management's largest Q1 2026 buy was Alumis Inc: 800,000 shares worth $17.6M.
  • Integral Health Asset Management added most to Insmed in Q1 2026, an estimated $38.4M increase.
  • Integral Health Asset Management's biggest Q1 2026 reduction was Intuitive Surgical, cutting an estimated $37.9M.
  • Integral Health Asset Management fully exited Medtronic in Q1 2026, selling an estimated $64.8M.
  • Integral Health Asset Management's ten largest holdings make up 45% of its $2.09B portfolio in Q1 2026.
  • Integral Health Asset Management opened 28 new positions and closed 24 in Q1 2026.
  • Integral Health Asset Management's portfolio value rose 3.8% quarter-over-quarter to $2.09B.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.